Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Physiomics ( (GB:PYC) ) has provided an update.
Physiomics plc has received a shareholder requisition to convene a general meeting seeking to overhaul its board, led by investor Michael Whitlow, who holds about 13.68% of the company’s share capital. The proposed resolutions would appoint four new directors and remove the existing four, amounting to a full board replacement if all motions pass.
The current board is taking legal advice to verify that the request complies with UK company law and, if valid, must call the meeting by early April with the vote to follow within 28 days of the notice. Directors, who had been in dialogue with Whitlow, publicly argue that a wholesale board change would be highly detrimental to the company and its shareholders, signalling a potentially contentious governance showdown that could reshape leadership and strategic direction.
The most recent analyst rating on (GB:PYC) stock is a Sell with a £0.48 price target. To see the full list of analyst forecasts on Physiomics stock, see the GB:PYC Stock Forecast page.
Spark’s Take on PYC Stock
According to Spark, TipRanks’ AI Analyst, PYC is a Neutral.
The score is held back primarily by weak financial performance (ongoing losses and persistent cash burn), partially offset by a low-leverage balance sheet and some improvement in price trend. Valuation is constrained by negative earnings and lack of dividend support.
To see Spark’s full report on PYC stock, click here.
More about Physiomics
Physiomics plc is a UK-based life sciences company specialising in modelling and simulation, biostatistics, data science and bioinformatics services for biotech and pharmaceutical clients. Leveraging proprietary tools such as its Virtual Tumour technology, the company supports decision-making across discovery, pre-clinical and clinical drug development, and has worked on more than 140 commercial projects for clients including Merck KGaA, Astellas and Cancer Research UK.
Average Trading Volume: 7,494,568
Technical Sentiment Signal: Sell
Current Market Cap: £1.52M
For a thorough assessment of PYC stock, go to TipRanks’ Stock Analysis page.